CN106432095A - 匹莫苯丹关键中间体6‑(3,4‑二氨基苯基)‑5‑甲基‑4,5‑二氢哒嗪‑3(2h)‑酮的制备 - Google Patents
匹莫苯丹关键中间体6‑(3,4‑二氨基苯基)‑5‑甲基‑4,5‑二氢哒嗪‑3(2h)‑酮的制备 Download PDFInfo
- Publication number
- CN106432095A CN106432095A CN201610814127.6A CN201610814127A CN106432095A CN 106432095 A CN106432095 A CN 106432095A CN 201610814127 A CN201610814127 A CN 201610814127A CN 106432095 A CN106432095 A CN 106432095A
- Authority
- CN
- China
- Prior art keywords
- methyl
- preparation
- reaction
- phenyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DZMGFWJPUPRKHU-UHFFFAOYSA-N CC(C1)C(c(cc2C)ccc2N)=NNC1=O Chemical compound CC(C1)C(c(cc2C)ccc2N)=NNC1=O DZMGFWJPUPRKHU-UHFFFAOYSA-N 0.000 description 1
- LVJXMQUFOJHLOF-UHFFFAOYSA-N CC(CC(O)=O)C(c(cc1C)ccc1NC(C)=O)=O Chemical compound CC(CC(O)=O)C(c(cc1C)ccc1NC(C)=O)=O LVJXMQUFOJHLOF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610814127.6A CN106432095B (zh) | 2016-09-09 | 2016-09-09 | 匹莫苯丹关键中间体6-(3,4-二氨基苯基)-5-甲基-4,5-二氢哒嗪-3(2h)-酮的制备 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610814127.6A CN106432095B (zh) | 2016-09-09 | 2016-09-09 | 匹莫苯丹关键中间体6-(3,4-二氨基苯基)-5-甲基-4,5-二氢哒嗪-3(2h)-酮的制备 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106432095A true CN106432095A (zh) | 2017-02-22 |
CN106432095B CN106432095B (zh) | 2019-04-16 |
Family
ID=58168259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610814127.6A Active CN106432095B (zh) | 2016-09-09 | 2016-09-09 | 匹莫苯丹关键中间体6-(3,4-二氨基苯基)-5-甲基-4,5-二氢哒嗪-3(2h)-酮的制备 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106432095B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4361563A (en) * | 1978-08-25 | 1982-11-30 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Pyridazinone-substituted benzimidazoles and salts |
CN103391939A (zh) * | 2010-12-03 | 2013-11-13 | Epizyme股份有限公司 | 作为表观遗传酶调节剂的经取代的嘌呤和7-氮杂嘌呤化合物 |
-
2016
- 2016-09-09 CN CN201610814127.6A patent/CN106432095B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4361563A (en) * | 1978-08-25 | 1982-11-30 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Pyridazinone-substituted benzimidazoles and salts |
CN103391939A (zh) * | 2010-12-03 | 2013-11-13 | Epizyme股份有限公司 | 作为表观遗传酶调节剂的经取代的嘌呤和7-氮杂嘌呤化合物 |
Non-Patent Citations (4)
Title |
---|
宫平等: "匹莫苯的合成", 《沈阳药科大学学报》 * |
朴日阳等: "新型强心药物--pimobendan的合成研究", 《中国药物化学杂志》 * |
王恩思等: "新型强心药物匹莫苯的合成", 《中国药物化学杂志》 * |
许佑君等: "强心药匹莫苯单水合物新合成方法研究", 《合成化学》 * |
Also Published As
Publication number | Publication date |
---|---|
CN106432095B (zh) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102036983B (zh) | 制备5-(2-氨基-嘧啶-4-基)-2-芳基-1h-吡咯-3-甲酰胺的方法 | |
JP2020526476A (ja) | オメカムティブメカルビルの合成 | |
CN106432095B (zh) | 匹莫苯丹关键中间体6-(3,4-二氨基苯基)-5-甲基-4,5-二氢哒嗪-3(2h)-酮的制备 | |
CN105272921A (zh) | 一种制备Ceritinib的方法及其中间体化合物 | |
CN107176948B (zh) | 匹莫苯丹的制备 | |
CN113583003A (zh) | 一种伐地那非类似物及其合成方法和应用 | |
WO2022011948A1 (zh) | 制备沃替西汀的方法 | |
CN111533742A (zh) | 以氰胺为原料合成2-甲氧基三甲基嘌呤二酮的方法 | |
US20050245742A1 (en) | Process for the preparation of zaleplon | |
KR20030068583A (ko) | 순수한 온단세트론 하이드로클로라이드 이수화물의 개선된제조 방법 | |
JPS6025428B2 (ja) | 4‐(ヒドロキシメチル)イミダゾール化合物の製法 | |
CN108976200B (zh) | 一种由合成匹莫苯丹的副产物制备匹莫苯丹的方法 | |
JPH08176150A (ja) | 5−クロロ−4−(2−イミダゾリン−2−イルアミノ)−2,1,3−ベンゾチアジアゾール又はその塩の製造方法 | |
JPH0558985A (ja) | シアノグアニジン誘導体の製造法 | |
CN106220633A (zh) | 一种含氯苯并吡嗪结构的1,2,4‑三唑衍生物作为杀菌剂的应用 | |
KR100856133B1 (ko) | 아토르바스타틴의 개선된 제조방법 | |
CN105968054B (zh) | 匹莫苯丹关键中间体的制备 | |
RU2626403C1 (ru) | Способ получения (2-гидроксинафталин-1-ил)азина | |
JP4328875B2 (ja) | アルキル−8−ニトロキサンチン誘導体 | |
JP4328873B2 (ja) | 放射線増感剤 | |
JP2959811B2 (ja) | 酸塩化物の製造法 | |
JPH07267950A (ja) | 5−クロロ−n−(4,5−ジヒドロ−1h−イミダゾール−2−イル)−2,1,3−ベンゾチアジアゾール−4−アミン又はその酸付加塩の製造方法 | |
JP2023033201A (ja) | オラパリブの製造方法 | |
CN117586250A (zh) | 一种人类呼吸道合胞病毒抑制剂中间体的制备方法 | |
KR101547142B1 (ko) | 피페라지닐알킬트리아졸 이성질체의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zou Ping Inventor after: Jiang Zhongxing Inventor after: Hu Lin Inventor after: Cao Lei Inventor after: Qiu Xiaolong Inventor after: Zhang Xingang Inventor after: Gou Shao Hua Inventor after: Peng Dehui Inventor after: Wang Donghui Inventor after: Zhang Yisen Inventor after: Deng Xianming Inventor after: You Zhengwei Inventor before: Qiu Xiaolong Inventor before: Hu Lin Inventor before: Cao Lei Inventor before: Chen Jun Inventor before: Zhang Xingang Inventor before: Peng Dehui Inventor before: Wang Donghui Inventor before: Zou Ping Inventor before: Zhang Yisen Inventor before: Deng Xianming Inventor before: You Zhengwei Inventor before: Jiang Zhongxing |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190314 Address after: No. 2, four archway in Xuanwu District, Nanjing, Jiangsu Applicant after: SOUTHEAST University Applicant after: WISDOM PHARMACEUTICAL Co.,Ltd. Address before: 226123 No. 18 Qinghua Road, three Factory Street, Haimen City, Nantong, Jiangsu Applicant before: WISDOM PHARMACEUTICAL Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 2, four archway in Xuanwu District, Nanjing, Jiangsu Patentee after: SOUTHEAST University Patentee after: Jiangsu Huiju Pharmaceutical Co.,Ltd. Address before: No. 2, four archway in Xuanwu District, Nanjing, Jiangsu Patentee before: SOUTHEAST University Patentee before: Jiangsu Huiju Pharmaceutical Co.,Ltd. Address after: No. 2, four archway in Xuanwu District, Nanjing, Jiangsu Patentee after: SOUTHEAST University Patentee after: Jiangsu Huiju Pharmaceutical Co.,Ltd. Address before: No. 2, four archway in Xuanwu District, Nanjing, Jiangsu Patentee before: SOUTHEAST University Patentee before: WISDOM PHARMACEUTICAL Co.,Ltd. |